Lansen Pharmaceutical Holdings Limited, owning several branches and sub-branches, is an investment and management platform established by Cathay International Holdings Limited for the development of medicine and health industry in China. The Company was listed on the main board of HKEX on May 7th, 2010 (Stock Code: 00503.HK). Lansen has two modern production plants operated in Ningbo, China